A serious adverse event secondary to rapid intravenous levetiracetam injection in a dog.
暂无分享,去创建一个
[1] D. Maria,et al. Characterization of mesenchymal stem cells derived from the equine synovial fluid and membrane , 2015, BMC Veterinary Research.
[2] G. Zaccara,et al. The adverse event profile of levetiracetam: A meta-analysis on children and adults , 2015, Seizure.
[3] C. Gurses,et al. Intravenous levetiracetam treatment in status epilepticus: A prospective study , 2015, Epilepsy Research.
[4] Qian Chen,et al. Pharmacokinetics, Safety and Bioequivalence of Levetiracetam Intravenous Infusion and Oral Tablets in Healthy Chinese Subjects , 2015, Clinical Drug Investigation.
[5] H. Volk,et al. Assessment into the usage of levetiracetam in a canine epilepsy clinic , 2015, BMC Veterinary Research.
[6] E. Patterson. Status epilepticus and cluster seizures. , 2014, The Veterinary clinics of North America. Small animal practice.
[7] D. Pearce,et al. The Human Synaptic Vesicle Protein, SV2A, Functions as a Galactose Transporter in Saccharomyces cerevisiae * ♦ , 2014, The Journal of Biological Chemistry.
[8] M. Wiese,et al. Immediate‐type hypersensitivity drug reactions , 2014, British journal of clinical pharmacology.
[9] E. Koklu,et al. Levetiracetam-induced anaphylaxis in a neonate. , 2014, Pediatric neurology.
[10] Y. Cortes,et al. Anaphylaxis in dogs and cats. , 2013, Journal of veterinary emergency and critical care.
[11] Xiao-feng Li,et al. Stevens–Johnson syndrome induced by levetiracetam , 2012, Seizure.
[12] R. McLachlan,et al. Levetiracetam induced angioedema in a patient with previous anticonvulsant hypersensitivity reaction to phenytoin and lamotrigine , 2012, Seizure.
[13] E. Patterson,et al. Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs. , 2012, Journal of veterinary internal medicine.
[14] Batool F. Kirmani,et al. Use of intravenous levetiracetam for management of acute seizures in neonates. , 2011, Pediatric neurology.
[15] A. Fischer,et al. Status epilepticus and epileptic seizures in dogs. , 2009, Journal of veterinary internal medicine.
[16] J. Wheless,et al. Rapid Infusion of a Loading Dose of Intravenous Levetiracetam With Minimal Dilution: A Safety Study , 2009, Journal of child neurology.
[17] Holger A Volk,et al. The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs. , 2008, Veterinary journal.
[18] E. Patterson,et al. Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics. , 2008, Journal of veterinary pharmacology and therapeutics.
[19] Curtis Wells Dewey,et al. Pharmacokinetics of single‐dose intravenous levetiracetam administration in normal dogs , 2008 .
[20] Curtis Wells Dewey,et al. Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy. , 2008, Journal of the American Veterinary Medical Association.
[21] S. Ramael,et al. Levetiracetam Intravenous Infusion: A Randomized, Placebo‐controlled Safety and Pharmacokinetic Study , 2006, Epilepsia.
[22] M. Morrell,et al. The KEEPER™ 1 KEEPER is a trademark of UCB S.A. 1 trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study , 2003, Epilepsy Research.
[23] S. Platt,et al. Canine status epilepticus: a retrospective study of 50 cases. , 2002, The Journal of small animal practice.
[24] C. Hovinga. Levetiracetam: A Novel Antiepileptic Drug , 2001, Pharmacotherapy.